These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 7516014

  • 1. Effects of perindopril on serum lipids in hypertensive patients with hyperlipidemia.
    Middeke M, Krone W.
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):629-31. PubMed ID: 7516014
    [Abstract] [Full Text] [Related]

  • 2. Metabolic neutrality of perindopril: focus on insulin sensitivity in overweight patients with essential hypertension.
    Böhlen L, Bienz R, Doser M, Papiri M, Shaw S, Riesen W, Weidmann P.
    J Cardiovasc Pharmacol; 1996 Jun; 27(6):770-6. PubMed ID: 8761842
    [Abstract] [Full Text] [Related]

  • 3. ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients.
    Fogari R, Zoppi A, Lazzari P, Preti P, Mugellini A, Corradi L, Lusardi P.
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):616-20. PubMed ID: 9781930
    [Abstract] [Full Text] [Related]

  • 4. Effects of perindopril on insulin sensitivity and plasma lipid profile in hypertensive non-insulin-dependent diabetic patients.
    Bak JF, Gerdes LU, Sørensen NS, Pedersen O.
    Am J Med; 1992 Apr 27; 92(4B):69S-72S. PubMed ID: 1580283
    [Abstract] [Full Text] [Related]

  • 5. ACE-inhibition with perindopril in essential hypertensive patients with concomitant diseases. The Perindopril Therapeutic Safety Collaborative Research Group.
    Overlack A, Adamczak M, Bachmann W, Bönner G, Bretzel RG, Derichs R, Krone W, Lederle RM, Reimann HJ, Zschiedrich H.
    Am J Med; 1994 Aug 27; 97(2):126-34. PubMed ID: 8059778
    [Abstract] [Full Text] [Related]

  • 6. A new trial of the efficacy, tolerability, and safety of angiotensin-converting enzyme inhibition in mild systemic hypertension with concomitant diseases and therapies. Perindopril Therapeutic Safety Study Group (PUTS).
    Stumpe KO, Overlack A.
    Am J Cardiol; 1993 Jun 24; 71(17):32E-37E. PubMed ID: 8328365
    [Abstract] [Full Text] [Related]

  • 7. Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension.
    Oksa A, Gajdos M, Fedelesová V, Spustová V, Dzúrik R.
    J Cardiovasc Pharmacol; 1994 Jan 24; 23(1):79-86. PubMed ID: 7511740
    [Abstract] [Full Text] [Related]

  • 8. Lipid profile and antihypertensive efficacy in hyperlipidemic hypertensive patients: comparison of rilmenidine and captopril.
    Scemama M, Février B, Beucler I, Dairou F.
    J Cardiovasc Pharmacol; 1995 Jan 24; 26 Suppl 2():S34-9. PubMed ID: 8642803
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A double-blind comparison of perindopril and hydrochlorothiazide-amiloride in mild to moderate essential hypertension.
    Andrejak M, Santoni JP, Carré A, Deruyttere M, Magometschnigg D, Gotzen R, Stumpe KO.
    Fundam Clin Pharmacol; 1991 Jan 24; 5(3):185-92. PubMed ID: 1682228
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antihypertensive efficacy of the ACE-inhibitor perindopril in the elderly.
    Leenen FH, Tanner J, McNally CF.
    J Hum Hypertens; 2000 May 24; 14(5):321-5. PubMed ID: 10822319
    [Abstract] [Full Text] [Related]

  • 16. Assessment of antihypertensive efficacy of perindopril: results of double-blind multicenter studies versus reference drugs.
    Thurston H, Desche P.
    J Cardiovasc Pharmacol; 1991 May 24; 18 Suppl 7():S45-9. PubMed ID: 1725202
    [Abstract] [Full Text] [Related]

  • 17. Effects of perindopril on glucose and lipid metabolism in patients with mild-to-moderate essential hypertension and glucose intolerance.
    Uchida K, Azukizawa S, Kigoshi T, Nakano S, Kaneko M, Morimoto S, Matsui A.
    Clin Ther; 1994 May 24; 16(3):466-70. PubMed ID: 7923313
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant nephropathy.
    Bönner G, Lederle RM, Scholze J, Stumpe KO.
    Arzneimittelforschung; 1993 Aug 24; 43(8):852-5. PubMed ID: 8216441
    [Abstract] [Full Text] [Related]

  • 20. Long-term (1 year) acceptability of perindopril in type II diabetic patients with hypertension.
    Jandrain B, Herbaut C, Depoorter JC, Voorde KV.
    Am J Med; 1992 Apr 27; 92(4B):91S-94S. PubMed ID: 1580288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.